AAVANTIBIO

Biological treatments, namely, biological preparations for use in the clinical, medicinal, and therapeutic treatment of Friedreich's Ataxia, genetic disorders, genetic diseases, and rare diseases; biopharmaceutical reagents for medical use, for use in gene therapy for the treatment of Friedreich's Ataxia, genetic disorders, genetic diseases, and rare diseases; biopharmaceutical preparations for human use for the treatment of Friedreich's Ataxia, genetic disorders, genetic diseases, and rare diseases

Biotechnology research and scientific research in the fields of Friedreich's Ataxia, genetic disorders, rare diseases, genetics, and genetic engineering in the nature of gene therapies, gene-editing services, DNA modeling services, and gene engineering services; providing medical research information in the fields of Friedreich's Ataxia and genetic disorders, gene therapies, genetic editing, and rare diseases via the internet and social media